These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25899750)

  • 21. Heart Rate Changes Prior to Freezing of Gait Episodes Are Related to Anxiety.
    Economou K; Quek D; MacDougall H; Lewis SJG; Ehgoetz Martens KA
    J Parkinsons Dis; 2021; 11(1):271-282. PubMed ID: 33074191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gait variability in Parkinson's disease: an indicator of non-dopaminergic contributors to gait dysfunction?
    Lord S; Baker K; Nieuwboer A; Burn D; Rochester L
    J Neurol; 2011 Apr; 258(4):566-72. PubMed ID: 21052710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of dopaminergic medication on gait automaticity in Parkinson's disease.
    Workman CD; Thrasher TA
    J Clin Neurosci; 2019 Jul; 65():71-76. PubMed ID: 30902437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced step length, not step length variability is central to gait hypokinesia in people with Parkinson's disease.
    Mak MK
    Clin Neurol Neurosurg; 2013 May; 115(5):587-90. PubMed ID: 22871383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
    Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
    Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease.
    Miller NS; Chou KL; Bohnen NI; Müller MLTM; Seidler RD
    Parkinsonism Relat Disord; 2018 Mar; 48():54-60. PubMed ID: 29249680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gait variability in Parkinson's disease: levodopa and walking direction.
    Bryant MS; Rintala DH; Hou JG; Collins RL; Protas EJ
    Acta Neurol Scand; 2016 Jul; 134(1):83-6. PubMed ID: 26399376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter-joint coordination with and without dopaminergic medication in Parkinson's disease: a case-control study.
    Saegner K; Romijnders R; Hansen C; Holder J; Warmerdam E; Maetzler W
    J Neuroeng Rehabil; 2024 Jul; 21(1):118. PubMed ID: 39003450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gait freezing in Parkinson's disease and the stride length sequence effect interaction.
    Chee R; Murphy A; Danoudis M; Georgiou-Karistianis N; Iansek R
    Brain; 2009 Aug; 132(Pt 8):2151-60. PubMed ID: 19433440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical Activity Underlying Gait Improvements Achieved With Dopaminergic Medication During Usual Walking and Obstacle Avoidance in Parkinson Disease.
    Orcioli-Silva D; Vitório R; Nóbrega-Sousa P; Beretta VS; Conceição NRD; Oliveira AS; Pereira MP; Gobbi LTB
    Neurorehabil Neural Repair; 2021 May; 35(5):406-418. PubMed ID: 33754884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ON-OFF Effects of Dopaminergic Therapy on Psychiatric Symptoms in Parkinson's Disease.
    Ganjavi H; MacDonald PA
    J Neuropsychiatry Clin Neurosci; 2015; 27(2):e134-9. PubMed ID: 25923857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype.
    Galna B; Lord S; Burn DJ; Rochester L
    Mov Disord; 2015 Mar; 30(3):359-67. PubMed ID: 25546558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic and non-dopaminergic gait components assessed by instrumented timed up and go test in Parkinson's disease.
    Dibilio V; Nicoletti A; Mostile G; Toscano S; Luca A; Raciti L; Sciacca G; Vasta R; Cicero CE; Contrafatto D; Zappia M
    J Neural Transm (Vienna); 2017 Dec; 124(12):1539-1546. PubMed ID: 29018993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological treatment in Parkinson's disease: Effects on gait.
    Smulders K; Dale ML; Carlson-Kuhta P; Nutt JG; Horak FB
    Parkinsonism Relat Disord; 2016 Oct; 31():3-13. PubMed ID: 27461783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of handheld video camera and GAITRite® measurement of gait impairment in people with early stage Parkinson's disease: a pilot study.
    Beijer TR; Lord SR; Brodie MA
    J Parkinsons Dis; 2013; 3(2):199-203. PubMed ID: 23938349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre- and unplanned walking turns in Parkinson's disease - Effects of dopaminergic medication.
    Conradsson D; Paquette C; Lökk J; Franzén E
    Neuroscience; 2017 Jan; 341():18-26. PubMed ID: 27867059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Freezing of gait in Parkinson's disease: further insights into pathophysiological mechanisms.
    Danoudis M; Iansek R; Simpson P
    Parkinsonism Relat Disord; 2012 Jun; 18(5):543-7. PubMed ID: 22397817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic contributions to distance estimation in Parkinson's disease: a sensory-perceptual deficit?
    Ehgoetz Martens KA; Ellard CG; Almeida QJ
    Neuropsychologia; 2013 Jul; 51(8):1426-34. PubMed ID: 23643554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side of basal ganglia degeneration influences freezing of gait in Parkinson's disease.
    Pieruccini-Faria F; Ehgoetz Martens KA; Silveira CR; Jones JA; Almeida QJ
    Behav Neurosci; 2015 Apr; 129(2):214-8. PubMed ID: 25730121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Balance problems with Parkinson's disease: are they anxiety-dependent?
    Pasman EP; Murnaghan CD; Bloem BR; Carpenter MG
    Neuroscience; 2011 Mar; 177():283-91. PubMed ID: 21219972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.